Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest CGMs Articles
Popular CGMs Articles
Highly Recommended CGMs Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
$3.7 Billion... Going Once... Going Twice... Sold!
Medtronic Acquires Minimed
On May 30, medical-devices maker Medtronic Inc. of Minneapolis agreed to buy insulin-pump maker MiniMed Inc. and Medical Research Group Inc.—a firm partly owned by MiniMed—for $3.7 billion.
Medtronic will pay $48 cash per share for the Northridge, California-based MiniMed, for a total of about $3.28 billion. The remaining $420 million will go toward the purchase of Medical Research Group, which designs and develops implantable pumps and sensors (i.e., an "artificial pancreas").
"MiniMed's market leadership in diabetes management offers immediate opportunities for reaching an expanding market that includes more than 16 million people in the United States,'' said Art Collins, chief executive of Medtronic.
Terrance Gregg, president and chief operating officer of MiniMed told Diabetes Health, "We do not expect our name, or the quality of service we provide to our customers, to change. Rather, we expect our relationship with Medtronic to help us advance our technologies at a faster rate and enable us to provide superior service and responsive clinical support to patients living with diabetes."
Gregg adds that Medtronic will provide MiniMed with the financial muscle necessary to grow even further.
"[This will enable] us to enrich the lives of patients living with diabetes each and every day," says Gregg.
Medtronic expects to complete the acquisitions within four months. Medtronic shares rose 22 cents to $43.17 in May 30 trading on the New York Stock Exchange. MiniMed shares rose $2.97, or 6.8 percent, to $46.97, in trading on the Nasdaq Stock Market.
Categories: Artificial Pancreas, CGMs, Diabetes, Diabetes, Insulin, Insulin Pumps, Monitoring, Products
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...